GlobalData on MSN5d
USPTO grants patent to Vistagen’s neuropathic pain treatmentThe USPTO has granted a patent to Vistagen’s non-opioid oral product candidate AV-101 for neuropathic pain treatment.
The Patent Eligibility Restoration Act (PERA) proposes a solution to a complex debate: What can be patented, and when do ...
Core Granted Two New U.S. PatentsROCKAWAY, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced ...
HotCopper.com on MSN6d
Neurizon snags US patent for NUZ-001 after winning FDA orphan status in 2024Neurizon (ASX:NUZ) has officially snagged a U.S. patent for its neurodegenerative disease and cancer drug candidate NUZ-001, ...
UnitedHealth CEO Andrew Witty’s recent public comments suggest he understands healthcare’s biggest problem. The question is: ...
According to Downdetector, PSN has been suffering from an outage since at least 3pm PST/6pm EST. The PlayStation Network ...
MicroStrategy is changing its name to reflect its transformation from strictly a software firm to the self-described "world's ...
Stockhead on MSN6d
Neurizon granted US patent for lead drug to treat motor neurone and other neurodegenerative conditionsA patent has been granted in the US covering the use of Neurizon’s lead drug candidate NUZ-001 in neurodegenerative diseases ...
On January 27, in Apple Inc. v. Gesture Technology Partners, LLC, the Federal Circuit held that the Patent Trial and Appeal Board (PTAB) ...
Unbelted passengers can also become dangerous projectiles, harming themselves and others inside the vehicle. The American ...
SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback